Fitness beyond age: Multidisciplinary expert opinion on redefining fitness for targeted therapies in chronic lymphocytic leukemia

Documenti analoghi

• Realizing precision medicine in chronic lymphocytic leukemia: Remaining challenges and potential opportunities
  di: Kostas Stamatopoulos, et al.
  Pubblicazione: (2024)
• Cumulative review of cardiac failure with acalabrutinib in the treatment of chronic lymphocytic leukemia using data from clinical trials and postmarketing experience
  di: Paolo Ghia, et al.
  Pubblicazione: (2025)
• A spheroid model that recapitulates the protective role of the lymph node microenvironment and serves as a platform for drug testing in chronic lymphocytic leukemia
  di: Elisa Lenti, et al.
  Pubblicazione: (2025)
• Outcomes and prognostic factors in 3306 patients with relapsed/refractory chronic lymphocytic leukemia treated with ibrutinib outside of clinical trials: A nationwide study
  di: Gian Matteo Rigolin, et al.
  Pubblicazione: (2024)
• Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real‐life experience
  di: Idanna Innocenti, et al.
  Pubblicazione: (2024)